Kiniksa Pharmaceuticals International (KNSA) Deferred Taxes (2017 - 2026)
Kiniksa Pharmaceuticals International (KNSA) posted Deferred Taxes of $4.5 million for Q1 2026, up 165.02% on a QoQ basis from -$7.0 million in Q4 2025, and up 51.12% year-over-year from $3.0 million in Q1 2025.
Kiniksa Pharmaceuticals International (KNSA) Deferred Taxes (2017 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International's Deferred Taxes history runs 10 years deep, the most recent figure standing at $4.5 million for Q1 2026.
- Quarterly Deferred Taxes rose 51.12% year-over-year to $4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.4 million (down 58.01% YoY) and the FY2025 annual result came in at $2.9 million, down 75.65% from the prior year.
- Deferred Taxes was $4.5 million for Q1 2026 at Kiniksa Pharmaceuticals International, up from -$7.0 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $10.6 million in Q2 2024 and bottomed at -$25.7 million in Q4 2023.
- A 5-year average of -$1.0 million and a median of $1.9 million in 2023 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2023 — Deferred Taxes tumbled 7487.64% — and 2024, when it soared 305.29%.
- Kiniksa Pharmaceuticals International's Deferred Taxes stood at $348000.0 in 2022, then tumbled by 7487.64% to -$25.7 million in 2023, then soared by 102.52% to $647000.0 in 2024, then sank by 1175.12% to -$7.0 million in 2025, then surged by 165.02% to $4.5 million in 2026.
- Business Quant data shows KNSA's Deferred Taxes at $4.5 million in Q1 2026, -$7.0 million in Q4 2025, and $4.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Kiniksa Pharmaceuticals International | 4.82 Bn | 4.36 Bn | 193.47 Mn | 4.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.52 Mn |
| Dec 31, 2025 | -6.96 Mn |
| Sep 30, 2025 | 4.23 Mn |
| Jun 30, 2025 | 2.64 Mn |
| Mar 31, 2025 | 2.99 Mn |
| Dec 31, 2024 | 647,000.00 |
| Sep 30, 2024 | -3.64 Mn |
| Jun 30, 2024 | 10.57 Mn |
| Mar 31, 2024 | 4.37 Mn |
| Dec 31, 2023 | -25.71 Mn |
| Sep 30, 2023 | 10.29 Mn |
| Jun 30, 2023 | -19.44 Mn |
| Mar 31, 2023 | 1.08 Mn |
| Dec 31, 2022 | 348,000.00 |
| Mar 31, 2021 | 10,000.00 |
| Dec 31, 2020 | 40,000.00 |
| Sep 30, 2020 | -51,000.00 |
| Jun 30, 2020 | 5.41 Mn |
| Mar 31, 2020 | -1.04 Mn |
| Dec 31, 2019 | 255,000.00 |